Public Health Crisis Cooperative Agreement Application - On this future date, the Florida Department of Health (DOH), through their syndromic surveillance program, recognized an increase in cases presenting with symptoms associated with highly infectious diseases. These cases presented in Florida’s most populated areas and, after investigations with healthcare professionals, the Department suspects they have cases of the highly infectious Disease X. Disease X is an emerging disease that is transmitted through inhalation and direct contact with bodily fluids. Currently, there are established medical countermeasures available. With an infection rate of 10% and a mortality rate of 50-60% when left untreated (or 10% when treated), the Department expects to observe approximately two million cases and between 200,000 to 1,000,000 deaths. The outputs below are based on the background and incorporates assumptions and actions that have been taken by the Department in previous responses. The work plan reflects activities typically taken at the on-set of a response as significant as a Public Health Emergency and those that would require additional financial support. It does not reflect the full capability of the Department, nor does it reflect activities in which the Department would not need financial assistance to conduct. If funds were awarded under this NOFO, the Department would revise the workplan to incorporate all activities and financial needs of that future event. Outputs: • Incident Management System in place to support objectives of incident. • Activation of call centers as deemed appropriate. • Current and accurate list of viable staffing augmentation vendors with costs. • Activation of staff augmentation memorandums of understanding. • Staff augmentation purchase requisitions prepared. • Enhanced logistical capability. • Increased communications, through multiple methods, for public to obtain information regarding infectious disease and maintain situation awareness. • Protected responder workforce for continuity of operations. • Enhanced logistical capacity to receive and distribute critical PPE, medical equipment, non-pharmaceutical interventions and MCM. • Enhanced capacity to address increased service needs due to PHE. • Enhancements to electronic disease surveillance systems operationalized • Enhanced DOH laboratory testing capacity.